Ultragenyx Pharmaceutical Inc
(MEX:RARE)
MXN
1,150.56
(0%)
Market Cap: 55.27 Bil
Enterprise Value: 44.11 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 66/100 Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 10:25AM GMT
Release Date Price:
MXN669.19
(+0.42%)
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Hi, everyone. My name is Farzin Haque. I'm an associate from Morris team at Jefferies. It's a pleasure to welcome Emil Kakkis, CEO of Ultragenyx. I think he has a few slides to start off with.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Yes.
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Welcome.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Thank you for having me. It's good to be in London. It's been so long since I've been in London. Walking around Covent Garden, been a while, it's been in a long time, too long. Happy to be here in London again, one of my favorite places and talk to you a little about where Ultragenyx is.
12 years ago with me and my secretary, couple of million dollars, and this is where we are today. With the commercial franchise, there is a forward-looking statement,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot